Nanostructured Lipid Carriers of Eperisone Hydrochloride using Quality By Design Approach

نویسندگان

چکیده

Objective: The current work involves formulation development of nanostructured lipid carrier (NLC) eperisone hydrochloride (EPE) using quality by design (QbD) approach.
 Materials and Methods: Initial screening solid liquid lipids was performed based on the Hansen solubility parameters EPE later confirmed saturation studies. optimum identified three-squared randomized full factorial design. High shear homogenization coupled with ultrasonication used to prepare NLCs. effect independent variables dependent analyzed response surface graphs ANOVA. optimized is characterized for mean particle size, zeta potential, entrapment efficiency, in vitro drug release subjected stability testing.
 Results Discussion: Precirol® ATO 5, CapryolTM 90, Pluronic® F127 are found be ideal lipid, surfactant respectively initial screening. Amount mixture (X1) amount (X2) were selected as efficiency (Y1), size (Y2) potential (Y3) variables. NLC has 175 nm, -24.4 mV 78.64%. data suggested that follows Quasi-Fickian diffusion. showed NLCs stable up 3 months at refrigerated conditions.
 Conclusions: parameter approach QbD a powerful tool sustained highly soluble poorly drugs.
 Keywords: Nanostructured carrier, Solubility Parameters, Nanoparticles, Lipid delivery, Quality Design

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Nanostructured Lipid Drug Carriers

solid lipid carriers – NLC. Particulate lipid matrices in the form of lipid pellets are known from the textbooks since many years, products are on the market (e. g. Mucosolvan retard, Boehringer-Ingelheim). After these lipid pellets as the first generation, P. Speiser developed so-called “lipid nanopellets for oral administration” in the middle of the eighties [1]. This system was not further d...

متن کامل

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers

The aim of this study is to prepare fluvastatin nanostructured lipid carriers (FLV-NLCs) in order to find an innovative way to alleviate FLV-associated disadvantages. The limitations include poor solubility and extensive first-pass metabolism, resulting in low (30%) bioavailability and short elimination half-life (1-3 hours). FLV-NLCs were prepared by hot emulsification-ultrasonication method. ...

متن کامل

Eperisone hydrochloride-induced maculopapular rash

Here, we report a case of a 30-year-old male who was prescribed eperisone hydrochloride for body pain and loose stools after which he developed severe maculopapular rash. Eperisone hydrochloride is an analgesic and antispastic drug used for spastic diseases such as spastic paralysis in cerebrovascular diseases, cervical spondylosis, and periarthritis. The drug is marketed in most of the Asian c...

متن کامل

Nanostructured lipid carriers: versatile oral delivery vehicle

Oral delivery is the most accepted and economical route for drug administration and leads to substantial reduction in dosing frequency. However, this route still remains a challenge for the pharmaceutical industry due to poorly soluble and permeable drugs leading to poor oral bioavailability. Incorporating bioactives into nanostructured lipid carriers (NLCs) has helped in boosting their therape...

متن کامل

Oral bioavailability enhancement of agomelatine by loading into nanostructured lipid carriers: Peyer’s patch targeting approach

Agomelatine (AGM) is a new antidepressant drug with a novel mechanism of action and fewer side effects compared with older antidepressants. AGM is a melatonin receptor (MT1 and MT2) agonist and 5-hydroxytryptamine receptor (5-HT2C) antagonist. In the present study, the enhancement of the oral bioavailability of AGM was formulated and loaded into nanostructured lipid carriers (NLCs), using ultra...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Drug Delivery and Therapeutics

سال: 2023

ISSN: ['2250-1177']

DOI: https://doi.org/10.22270/jddt.v13i2.5938